Editorial: Cardiovascular remodeling

Front Pharmacol. 2023 Jul 24:14:1252598. doi: 10.3389/fphar.2023.1252598. eCollection 2023.


Keywords: cardiovascular diseases (CVDs); cardiovascular remodeling; drug therapy; dysfunction; genetic studies.

Publication types

  • Editorial

Grants and funding

This work was supported by the National Natural Science Foundations of China (grant numbers 31972909, 82070502, and 32171099) and the Sichuan Science and Technology Program (grant numbers 2022YFS0607, 23NSFSC1456, and 2021YJ0213).